Literature DB >> 21143026

Targeted delivery of RNAi therapeutics for cancer therapy.

Jun Li, Leaf Huang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21143026     DOI： 10.2217/nnm.10.124

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN： 1743-5889            Impact factor:   5.307


× No keyword cloud information.
  9 in total

1.  Nanomaterials as Non-viral siRNA Delivery Agents for Cancer Therapy.

Authors:  Sanjay Singh
Journal:  Bioimpacts       Date:  2013-01-14

2.  High-throughput screening identifies small molecules that enhance the pharmacological effects of oligonucleotides.

Authors:  B Yang; X Ming; C Cao; B Laing; A Yuan; M A Porter; E A Hull-Ryde; J Maddry; M Suto; W P Janzen; R L Juliano
Journal:  Nucleic Acids Res       Date:  2015-02-06       Impact factor: 16.971

3.  Knockdown of RRS1 by lentiviral-mediated RNAi promotes apoptosis and suppresses proliferation of human hepatocellular carcinoma cells.

Authors:  Jitao Wang; Zhi Li; Changzeng Zuo; Qingfan Xie; Hui Li; Junhong Jia; Zhongguang Zhen; Ruizhao Qi; Zhiwei Li; Dengxiang Liu; Baijun Sun
Journal:  Oncol Rep       Date:  2017-08-14       Impact factor: 3.906

4.  Optimization of Formulations Consisting of Layered Double Hydroxide Nanoparticles and Small Interfering RNA for Efficient Knockdown of the Target Gene.

Authors:  Yanheng Wu; Wenyi Gu; Chen Chen; Son Trong Do; Zhi Ping Xu
Journal:  ACS Omega       Date:  2018-05-02

Review 5.  Bioconjugates for targeted delivery of therapeutic oligonucleotides.

Authors:  Xin Ming; Brian Laing
Journal:  Adv Drug Deliv Rev       Date:  2015-02-15       Impact factor: 15.470

Review 6.  Progress on RNAi-based molecular medicines.

Authors:  Jing Chen; Jianping Xie
Journal:  Int J Nanomedicine       Date:  2012-07-26

7.  Cdk2 silencing via a DNA/PCL electrospun scaffold suppresses proliferation and increases death of breast cancer cells.

Authors:  Clément Achille; Sowmya Sundaresh; Benjamin Chu; Michael Hadjiargyrou
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

8.  Efficient and tumor-specific knockdown of MTDH gene attenuates paclitaxel resistance of breast cancer cells both in vivo and in vitro.

Authors:  Liu Yang; Yanhua Tian; Wei Sun Leong; Heng Song; Wei Yang; Meiqi Wang; Xinle Wang; Jing Kong; Baoen Shan; Zhengchuan Song
Journal:  Breast Cancer Res       Date:  2018-09-18       Impact factor: 6.466

Review 9.  Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy.

Authors:  Sepideh Mirzaei; Mohammad Hossein Gholami; Hui Li Ang; Farid Hashemi; Ali Zarrabi; Amirhossein Zabolian; Kiavash Hushmandi; Masoud Delfi; Haroon Khan; Milad Ashrafizadeh; Gautam Sethi; Alan Prem Kumar
Journal:  Cells       Date:  2021-11-29       Impact factor: 6.600
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.